pH responsive dextran nanoparticles loaded with doxorubicin and RITA against cancer cells: synergistic inhibitory effects
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Weidong H, Linlin S, Lulu R, Liqian Z, Tongyu L, Yiting Q, Hangxiang W (2018) A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer. Signal Transduct Target Ther 3:1610.1038/s41392-018-0019-4 ↗
2. Bayat MR, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H (2017) Combination therapy in combating cancer. Oncotarget 8(23):38022–3804310.18632/oncotarget.16723 ↗
3. Manan FA, Yusof NA, Abdullah J, Mohammad F, Nurdin A, Yazan LS, Khiste SK, Al-Lohedan HA (2021) Drug release profiles of mitomycin C encapsulated quantum dots–chitosan nanocarrier system for the possible treatment of non-muscle invasive bladder cancer. Pharmaceutics 13(9):137910.3390/pharmaceutics13091379 ↗
4. Fonseca SB, Chorilli M (2020) The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems. Int J Pharm 589:11983210.1016/j.ijpharm.2020.119832 ↗
5. Wahab S, Alshahrani MY, Ahmad MF, Abbas H (2021) Current trends and future perspectives of nanomedicine for the management of colon cancer. Eur J Pharmacol 910:17446410.1016/j.ejphar.2021.174464 ↗
6. Xiuli Z, Dayi P, Guonian Z, Lu Z, Apanpreet B, Rongjun C, Hu Z, Qiyong G, Zhongwei G, Kui L (2022) A Dendritic polymer-based nanosystem mediates drug penetration and irreversible endoplasmic reticulum stresses in tumor via neighboring effect. Adv Mater 34(20):220120010.1002/adma.202201200 ↗
7. Hu X, Zhai S, Liu G, Xing D, Liang H, Liu S (2018) Concurrent drug unplugging and permeabilization of polyprodrug-gated crosslinked vesicles for cancer combination chemotherapy. Adv Mater 30(21):e170630710.1002/adma.201706307 ↗
8. Yaping W, Junmin Q, Ming Y, Weijun X, Jinlei W, Guanghui H, Lijie J, Aili S (2019) Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer. Carbohydr Polym 225:11520610.1016/j.carbpol.2019.115206 ↗
9. Wei L, Changshan S, Tongying J, Yikun G, Yang Y, Qinfu Z, Siling W (2019) Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy. Mater Sci Eng C 105:11010310.1016/j.msec.2019.110103 ↗
10. Zhilin L, Hao C, Zhiqian L, Long R, Xuelei M, Hongyan Z, Qiyong G, Hu Z, Zhongwei G, Kui L (2023) A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody. Bioact Mater 21:299–312
11. Qi SS, Sun JH, Yu HH, Yu SQ (2017) Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy. Drug Deliv 24(1):1909–192610.1080/10717544.2017.1410256 ↗
12. Singh M, Jadhav HR (2018) Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors. Drug Discov Today 23(3):745–75310.1016/j.drudis.2017.10.004 ↗
13. Li Y, Lin J, Ma J, Song L, Lin H, Tang B, Chen D, Su G, Ye S, Zhu X, Luo F (2017) Methotrexate–camptothecin prodrug nanoassemblies as a versatile nanoplatform for biomodal imaging-guided self-active targeted and synergistic chemotherapy. ACS Appl Mater Interfaces 9(40):34650–3466510.1021/acsami.7b10027 ↗
14. Sabra S, Abdelmoneem M, Abdelwakil M et al (2017) Self-assembled nanocarriers based on amphiphilic natural polymers for anti- cancer drug delivery applications. Curr Pharm Des 23(35):5213–5229
15. Tong X, Pan W, Su T, Zhang M, Dong W, Qi X (2020) Recent advances in natural polymer-based drug delivery systems. React Funct Polym 148:10450110.1016/j.reactfunctpolym.2020.104501 ↗
16. Huang S, Huang G (2019) The dextrans as vehicles for gene and drug delivery. Future Med Chem 11(13):1659–166710.4155/fmc-2018-0586 ↗
17. Huang G, Huang H (2018) Application of dextran as nanoscale drug carriers. Nanomedicine (Lond) 13(24):3149–315810.2217/nnm-2018-0331 ↗
18. Hien VN, Katrin C, Gavin FP, Sarah LY, Greg FW (2020) Nanoparticle system based on amino-dextran as a drug delivery vehicle: immune-stimulatory cpg-oligonucleotide loading and delivery. Pharmaceutics 12(12):115010.3390/pharmaceutics12121150 ↗
19. Aumelas A, Serrero A, Durand A, Dellacherie E, Leonard M (2007) Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems. Colloids Surf B 59(1):74–8010.1016/j.colsurfb.2007.04.021 ↗
20. Bertholon I, Vauthier C, Labarre D (2006) Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 23(6):1313–132310.1007/s11095-006-0069-0 ↗
21. Noa R, Ran B, Moshe O, Varda R (2011) Mutations in the p53 Tumor Suppressor Gene. Genes Cancer 2(4):466–47410.1177/1947601911408889 ↗
22. Richard JJ, Chad CB, Veerabhadran B, Deborah JK, Robert ZO (2012) Drug resistance to inhibitors of the human double minute-2 E3 ligase is mediated by point mutations of p53, but can be overcome with the p53 targeting agent RITA. Mol Cancer Ther 11(10):2243–225310.1158/1535-7163.MCT-12-0135 ↗
23. Cheok CF, Verma CS, Baselga J, Lane DP (2011) Translating p53 into the clinic. Nat Rev Clin Oncol 8:25–3710.1038/nrclinonc.2010.174 ↗
24. Shijie Z, Feng Z, Junyu Y, Xican Z, Guangbao Y, Xiaowen L (2020) pH-sensitive biomaterials for drug delivery. Molecules 25(5649):1–20
25. Kapoor R, Singh S, Tripathi M, Bhatnagar P, Kakkar P, Gupta KC (2014) O-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes. PLoS ONE 9(2):e8912410.1371/journal.pone.0089124 ↗
26. Bhosale R, Singhal R (2006) Process optimization for the synthesis of octenyl succinyl derivative of waxy corn and amaranth starches. Carbohydr Polym 66(4):521–52710.1016/j.carbpol.2006.04.007 ↗
27. Ding B, Wahid MA, Wang Z, Xie C, Thakkar A, Prabhu S, Wang J (2017) Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells. Nanoscale 9(32):11739–1175310.1039/C7NR03016A ↗
28. Bhatnagar P, Kumari M, Pahuja R, Pant AB, Shukla Y, Kumar P, Gupta KC (2018) Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Drug Deliv Transl Res 8(3):565–57910.1007/s13346-018-0485-9 ↗
29. Shijie Z, Feng Z, Junyu Y, Xican Z, Guangbao Y, Xiaowen L (2020) pH-sensitive biomaterials for drug delivery. Molecules 25(23):564910.3390/molecules25235649 ↗
30. Sidra K, Muhammad N, Ali A, Azka A, Farhat F, Amir F, Basit Y (2021) Reduction-sensitive dextran–paclitaxel polymer–drug conjugate: synthesis, self-assembly into nanoparticles, and in vitro anticancer efficacy. Bioconjugate Chem 32(12):2516–252910.1021/acs.bioconjchem.1c00492 ↗